发明名称 |
Use of compounds ?-D or ?-l nucleoside for treating hepatitis C virus |
摘要 |
<p>The present invention provides pharmaceutical compositions for the treatment of a hepatitis C infection in a host, comprising an antivirally effective amount of a 2'-C-branched nucleoside or a 2'-C-branched ribofuranosyl nucleoside, or pharmaceutically acceptable salts or esters thereof, in combination with one or more other anti-HCV agent. The present invention further provides the use of a 2'-C-branched nucleoside or a 2'-C-branched ribofuranosyl nucleoside, or pharmaceutically acceptable salts or esters thereof, in the manufacture of a medicament for the treatment of a hepatitis C infection in a host.</p> |
申请公布号 |
AP1782(A) |
申请公布日期 |
2007.09.28 |
申请号 |
AP20020002704 |
申请日期 |
2001.05.23 |
申请人 |
IDENIX (CAYMAN) LIMITED;UNIVERSITA DEGLI STUDI DI CAGLIARI |
发明人 |
SOMMADOSSI JEAN-PIERRE;LACOLLA PAOLO |
分类号 |
C07D473/18;A61K31/513;A61K31/52;A61K31/522;A61K31/7068;A61K31/7072;A61K31/7076;A61K31/708;A61P1/16;A61P31/12;A61P31/14;C07D405/04;C07D473/30;C07D473/34;C07H19/04;C07H19/06;C07H19/067;C07H19/073;C07H19/10;C07H19/16;C07H19/167;C07H19/173;C07H19/20 |
主分类号 |
C07D473/18 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|